54 results
8-K
EX-3.1
CORT
Corcept Therapeutics Inc
11 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:34pm
are commonly incident to the office of chief executive or which are delegated to him or her by the Board of Directors. The Chief Executive Officer
8-K
EX-1.1
CORT
Corcept Therapeutics Inc
6 Jul 12
Corcept Therapeutics Commences Public Offering of Common Stock
12:00am
)Payment of Expenses. The Company will pay all expenses incident to the performance of its obligations under this Agreement, including any filing fees … of airplanes, fees and expenses incident to listing the Offered Securities on the NASDAQ Stock Market and other national and foreign exchanges, fees
8-K
EX-10.1
xs6pdx27p73z8rtm tpe
29 Mar 12
Corcept Therapeutics Announces Exercise of Warrants
12:00am
8-K
1kwklcgyru6
29 Mar 12
Corcept Therapeutics Announces Exercise of Warrants
12:00am
8-K
EX-4.2
b1jchnk dsqcooj5xgs4
29 Mar 12
Corcept Therapeutics Announces Exercise of Warrants
12:00am
8-K
EX-1.1
1yd 24gs6tzj
21 Jan 11
Corcept Therapeutics Announces Pricing of $39.0 Million
12:00am
10-K/A
jcohfn5yzhltkz365d
19 Aug 10
Annual report (amended)
12:00am
8-K
EX-1.1
sfbc1c7p qh
25 Jun 10
Corcept Therapeutics Announces Pricing of $15 Million
12:00am
8-K
EX-10.1
1urqv7tgj559qtsxm3d
23 Apr 10
Corcept Therapeutics Announces Exercise of Existing Warrants
12:00am
8-K
EX-4.2
631e2jnm22inzh99rv49
23 Apr 10
Corcept Therapeutics Announces Exercise of Existing Warrants
12:00am